Amit P. Amin

Amit P. Amin

Auto-generated profile, based on publicly available information

Amit P. Amin

Interventional Cardiology, Rush University Medical Center, Chicago, Illinois, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
AAAmit P. Amin
Amit P. Amin
MPMark Patterson
Mark Patterson
JHJohn A. House
John A. House
HGHelmut Giersiefen
Helmut Giersiefen
JSJohn A. Spertus
John A. Spertus
SMSteven P. Marso
Steven P. Marso

1 November 2018 in JAMA Cardiology
Verified
Journal Article
Closed access
PDF file
AAAmit P. Amin
Amit P. Amin
DPDuane Pinto
Duane Pinto
JHJohn A. House
John A. House
SRSunil V. Rao
Sunil V. Rao
JSJohn A. Spertus
John A. Spertus
HKHemant Kulkarni
Hemant Kulkarni
Elective percutaneous coronary intervention (PCI) is common in the United States, performed in approximately half of the 600 000 PCI procedures that are conducted annually.1 With the increasing pressure on hospitals to improve the quality and value of their services, reducing the costs of elective PCI is an important opportunity to explore. In fact, alternative payment models, such as the Centers for Medicare and Medicaid Services episode payment models, commonly known as “bundled payments,” are influencing hospitals to prepare for the shift in reimbursements from “payment for volume” to “payment for value.”2

1 September 2017 in JAMA Cardiology
Verified
Journal Article
Open access
PDF file
AAAmit P. Amin
Amit P. Amin
RBRichard G. Bach
Richard G. Bach
MCMary L. Caruso
Mary L. Caruso
KKKevin F. Kennedy
Kevin F. Kennedy
JSJohn A. Spertus
John A. Spertus
Acute kidney injury (AKI) after percutaneous coronary intervention (PCI) is common, occurring in 7% of patients,1,2 but is a severely morbid and costly event that increases the risk of dialysis and mortality.1-4 Because hydration has modest benefit and administration of sodium bicarbonate and N-acetylcysteine has not proved to be effective in preventing AKI,5-7 reducing contrast volume may be the most effective strategy for preventing AKI.8

20 February 2018 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
AAAmit P. Amin
Amit P. Amin
PCPatricia Crimmins‐Reda
Patricia Crimmins‐Reda
SMSamantha Miller
Samantha Miller
BRBrandon Rahn
Brandon Rahn
MCMary Caruso
Mary Caruso
JSJasvindar Singh
Jasvindar Singh
Background: Same‐day discharge ( SDD ) after elective percutaneous coronary intervention is safe, less costly, and preferred by patients, but it is usually performed in low‐risk patients, if at all. To increase the appropriate use of SDD in more complex patients, we implemented a “patient‐centered” protocol based on risk of complications at Barnes‐Jewish Hospital. Methods and Results: Our objectives were as follows: (1) to evaluate time trends in SDD ; (2) to compare (a) mortality, bleeding, and acute kidney injury, (b) patient satisfaction, and (c) hospital costs by SDD versus no SDD ( NSDD ); and (3) to compare SDD eligibility by our patient‐centered approach versus Society for Cardiovascular Angiography and Interventions guidelines. Our patient‐centered approach was based on prospectively identifying personalized bleeding, mortality, and acute kidney injury risks, with a personalized safe contrast limit and mitigating those risks. We analyzed Barnes‐Jewish Hospital's National Cardiovascular Data Registry Cath PCI Registry data from July 1, 2009 to September 30, 2015 (N=1752). SDD increased rapidly from 0% to 77% ( P <0.001), independent of radial access. Although SDD patients were comparable to NSDD patients, SDD was not associated with adverse outcomes (0% mortality, 0% bleeds, and 0.4% acute kidney injury). Patient satisfaction was high with SDD . Propensity score–adjusted costs were $7331 lower/ SDD patient ( P <0.001), saving an estimated $1.8 million annually. Only 16 patients (6.95%) met the eligibility for SDD by Society for Cardiovascular Angiography and Interventions guidelines, implying our patient‐centered approach markedly increased SDD eligibility. Conclusions: With a patient‐centered approach, SDD rapidly increased and was safe in 75% of patients undergoing elective percutaneous coronary intervention, despite patient complexity. Patient satisfaction was high, and hospital costs were lower. Patient‐centered decision making to facilitate SDD is an important opportunity to improve the value of percutaneous coronary intervention.

1 May 2022 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
MZMichel Zeitouni
Michel Zeitouni
MGMarquis-Gravel Guillaume
Marquis-Gravel Guillaume
NSNathaniel R. Smilowitz
Nathaniel R. Smilowitz
PZPearl Zakroysky
Pearl Zakroysky
DWDaniel M. Wojdyla
Daniel M. Wojdyla
TWTracy Y. Wang
Tracy Y. Wang
Background: Mechanical circulatory support (MCS) devices can be used in high-risk percutaneous coronary intervention (PCI). Our objective was to describe trends and outcomes of prophylactic MCS use in elective PCI for patients with stable coronary artery disease in the American College of Cardiology National Cardiovascular Data Registry’s CathPCI registry. Methods: Among 2 108 715 consecutive patients with stable coronary artery disease undergoing elective PCI in the CathPCI registry between 2009 and 2018, we examined patterns of prophylactic use of MCS. Propensity score models with inverse probability of treatment weighting compared effectiveness (in-hospital death, cardiogenic shock, or new heart failure) and safety (stroke, tamponade, major bleeding, or vascular complication requiring treatment) between patients treated with intra-aortic balloon pump versus other MCS (Impella or extracorporeal membrane oxygenation). Results: Overall, 6905 (0.3%) patients underwent elective PCI with prophylactic MCS. MCS use trended up from 0.2% of elective PCIs in 2009 to 0.6% in 2018 ( P <0.0001), driven by other MCS ( P <0.0001), whereas intra-aortic balloon pump use remained low and constant ( P =0.12). In-hospital major adverse cardiac events and cardiovascular complications occurred in 7.1% and 18.8% of elective PCI patients with prophylactic MCS use and 0.5% and 2.3% of patients without prophylactic MCS use. Intra-aortic balloon pump use was associated with a higher risk of major adverse cardiac events (9.6% versus 6.0%, adjusted odds ratio, 1.59 [95% CI, 1.32–1.91]) but lower risk of complications (18.2% versus 19.1%, adjusted odds ratio, 0.88 [95% CI, 0.77–0.99]) than use of other MCS. Conclusions: The use of prophylactic MCS has increased over time for elective PCI in patients with stable coronary artery disease. Intra-aortic balloon pump was associated with higher major adverse cardiac events but lower risk of procedural complications compared with other MCS.

1 January 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
AAAmit P. Amin
Amit P. Amin
CMChristian McNeely
Christian McNeely
JSJohn A. Spertus
John A. Spertus
RBRichard G. Bach
Richard G. Bach
NFNathan Frogge
Nathan Frogge
FMFrederick A. Masoudi
Frederick A. Masoudi